5 Jul 2017 | The Motley Fool
So-called pot stocks have been popular on the ASX since the start of 2017, with a number seeing their share prices rocket up.
4 Jul 2017 | The West Australian
ASX-listed MGC Pharmaceuticals has moved nearly 500 marijuana plants to its growing facilities in the Czech Republic as it advances its European medicinal cannabis operations.
3 Jul 2017 | New Cannabis Ventures
Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015.
30 Jun 2017 | AgFunder News
It would be easy to see the first ever cannabis sponsor of the three-year-old Forbes AgTech Summit as a sign that legal, commercial cannabis has finally arrived.
27 Jun 2017 | The Australian
Bod Australia is looking to cash in on expected demand for cannabis-based treatments through plans to import an oil used to help children with epilepsy.
26 Jun 2017 | CNBC
Artificial intelligence is being used to improve banking, marketing, the legal field — and now to find which one of the more than 30,000 strains of medical marijuana is best for you.
26 Jun 2017 | Leafly
An Israeli company will partner with an Australian one to help boost clinical education opportunities around medical cannabis.
26 Jun 2017 | Fin Feed
Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc.
22 Jun 2017 | Stock News Now
Cannabis Science, Inc., a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch.